Fever as a marker of reactogenicity of an acellular pertussis-containing hexavalent vaccine (HEXAVAC (R)) in a large-scale, open, randomized safety study in healthy French infants
- Resource Type
- Journal
- Source
HUMAN VACCINES ; SEP-OCT 2006, 2 5, p215-p221, 7p.- Subject
- Language
- English
- ISSN
- 15548619